SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-006917
Filing Date
2022-01-24
Accepted
2022-01-24 16:30:48
Documents
14
Period of Report
2022-01-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm224288-1_8k.htm   iXBRL 8-K 26547
2 EXHIBIT 99.1 tm224288d1_ex99-1.htm EX-99.1 19885
6 GRAPHIC image_001.jpg GRAPHIC 34819
  Complete submission text file 0001104659-22-006917.txt   274771

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctso-20220124.xsd EX-101.SCH 3045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctso-20220124_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctso-20220124_pre.xml EX-101.PRE 22603
8 EXTRACTED XBRL INSTANCE DOCUMENT tm224288-1_8k_htm.xml XML 3602
Mailing Address 7 DEER PARK DRIVE, SUITE K MONMOUTH JUNCTION NJ 08852
Business Address 7 DEER PARK DRIVE, SUITE K MONMOUTH JUNCTION NJ 08852 973-329-8885
Cytosorbents Corp (Filer) CIK: 0001175151 (see all company filings)

IRS No.: 980373793 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36792 | Film No.: 22549754
SIC: 3841 Surgical & Medical Instruments & Apparatus